What is BioDynamix™ Anastomosis?BioDynamix™ Anastomosis, the novel closure technology for colorectal surgery, involves applying consistent compression to sections of the intestine after surgery in order to fascilitate natural healing. Used in the ColonRing™, BioDynamix™ Anastomosis satisfies several important clinical goals: creating a large patent lumen, leaving no permanent foreign body behind inside the bowel lumen, and preserving the natural tissue structure.
How does ColonRing™ differ from existing surgical standards? The current surgical standard for reconnecting the resected bowel involves surgical staples and stapling devices, which can crush and puncture tissue. Stapling hinders the natural healing process and the natural structure of the resected bowel. Surgical staples, being permanent implants, leave a foreign material within the body. The bowel is often left with a reduced lumen size. Further, multiple circular stapler sizes must be stocked to address specific sizing issues. ColonRing™ with BioDynamix™ Anastomosis technology addresses these drawbacks. The ring creates no through bowel wall punctures, enabling natural healing to occur. It leaves no permanent foreign material inside the bowel lumen. Studies have demonstrated that ColonRing™ preserves full lumen size. Only one size is needed for anastomosis of the intestine, so stocking of multiple sizes is unnecessary. Unlike stapling devices, the ColonRing™ applicator is not withdrawn from the body through the newly created anastomosis. This eliminates the potential for trauma to the anastomosis site.
End-to-end (left) and end-to-side (right) anastomoses 3 months post surgery.
Early anastomosis devices used steel, other non-elastic metals, or biodegradable materials that did not effectively accommodate variations in tissue thickness. This led to peripheral ischemia and an uneven necrotic process. The ColonRing™ incorporates Nitinol, an advanced metal alloy that exhibits “shape memory,” the ability to return to its original shape after being deformed. In addition, it applies a consistent force range as it returns to its original shape. In the ColonRing™, Nitinol leaf springs stretch to open the ring. After the ring is set during surgery, it gradually returns to its original closed position, adapting to variations in tissue thickness and accommodating compressed tissue. The Nitinol leaf springs apply a constant force range of pressure around the full circumference of the anastomosis. The result is a full circumferential, hemostatic sealed anastomosis.
The safety and efficacy of the ColonRing™ have been demonstrated in publications of pre-clinical and clinical trials and in commercial use, including company data from over 8,000 cases in North America, Europe, South Africa, and Israel. This analysis showed that successful anastomosis was independent of distance from the anal verge, as well as patient age, sex, and BMI, and concluded that the ColonRing™ provides a durable, safe and effective anastomosis with minimal or no visible scarring and wide and open lumen. ColonRing™ was shown to be efficacious even in the most challenging low and chemo-radiated cases. In company data, 39% of procedures (n=402) were performed at 10 cm or less from the anal verge. Out of over 3,500 AR procedures performed, more than 450 involved chemo-radiated patients. Pre-clinical and clinical data also show that ColonRing™ provides:
ColonRing™ is deployed with a device very similar to that used for circular staples, designed to minimize the surgeon’s learning curve. It is intuitive to use and easy to teach.
Many institutions have begun or are beginning targeted public relations efforts to make the public aware that they are offering this novel technology. NiTi Surgical Solutions has also prepared press releases, fact sheets, product and procedure B-roll, and photography for use by your institution in highlighting this important device. In addition, NiTi has created a patient brochure that assists the surgeon in explaining the procedure to the patient. Finally, NiTi maintains an archive of institutions’ public relations efforts available for your review.
ColonRing™ is designed to minimize the high costs associated with the complications of circular staples, including leakage, inflammation, infection, and bleeding. However, the institutional cost remains only slightly advanced over current circular staplers. Long-term economic impact studies have not been conducted.
The ColonRing™ does not eliminate the complications associated with the surgery or the anastomosis, which may include leakage, stricture, bleeding, septic complications, extra-colonic complications and others, which are the same to those reported with other methods (e.g. staplers). Please contact us for additional information. |
ACDS
23rd Annual International Colorectal Disease Symposium
February 15-18, 2012
Fort Lauderdale, Florida, USA
ASCRS Annual Meeting
June 2-6, 2012
San Antonio, TX, USA
www.fascrs.org